180 related articles for article (PubMed ID: 26402453)
1. Release of growth-differentiation factor 15 and associations with cardiac function in adult patients with congenital heart disease.
Eindhoven JA; van den Bosch AE; Oemrawsingh RM; Baggen VJ; Kardys I; Cuypers JA; Witsenburg M; van Schaik RH; Roos-Hesselink JW; Boersma E
Int J Cardiol; 2016 Jan; 202():246-51. PubMed ID: 26402453
[TBL] [Abstract][Full Text] [Related]
2. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease.
Eindhoven JA; van den Bosch AE; Ruys TP; Opić P; Cuypers JA; McGhie JS; Witsenburg M; Boersma E; Roos-Hesselink JW
J Am Coll Cardiol; 2013 Sep; 62(13):1203-12. PubMed ID: 23916937
[TBL] [Abstract][Full Text] [Related]
3. High-sensitive troponin-T in adult congenital heart disease.
Eindhoven JA; Roos-Hesselink JW; van den Bosch AE; Kardys I; Cheng JM; Veenis JF; Cuypers JAAE; Witsenburg M; van Schaik RHN; Boersma E
Int J Cardiol; 2015 Apr; 184():405-411. PubMed ID: 25746495
[TBL] [Abstract][Full Text] [Related]
4. [Plasma concentration of growth-differentiation factor-15 in children with congenital heart disease: relation ship to heart function and diagnostic value in heart failure].
Li Y; Wang XM; Liu YL; Shi K; Yang YF; Guo YH
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Feb; 15(2):95-8. PubMed ID: 23428120
[TBL] [Abstract][Full Text] [Related]
5. Plasma Growth Differentiation Factor-15 is a Potential Biomarker for Pediatric Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.
Li G; Li Y; Tan XQ; Jia P; Zhao J; Liu D; Wang T; Liu B
Pediatr Cardiol; 2017 Dec; 38(8):1620-1626. PubMed ID: 28819713
[TBL] [Abstract][Full Text] [Related]
6. Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy.
Montoro-García S; Hernández-Romero D; Jover E; García-Honrubia A; Vilchez JA; Casas T; Martínez P; Climent V; Caballero L; Valdés M; Marín F
Eur J Intern Med; 2012 Mar; 23(2):169-74. PubMed ID: 22284249
[TBL] [Abstract][Full Text] [Related]
7. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
[TBL] [Abstract][Full Text] [Related]
8. Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism.
Lankeit M; Kempf T; Dellas C; Cuny M; Tapken H; Peter T; Olschewski M; Konstantinides S; Wollert KC
Am J Respir Crit Care Med; 2008 May; 177(9):1018-25. PubMed ID: 18263797
[TBL] [Abstract][Full Text] [Related]
9. Growth differentiation factor 15--an early marker of abnormal function of the Fontan circuit in patients with univentricular hearts.
Raedle-Hurst TM; Koenigstein K; Gruenhage F; Raedle J; Herrmann E; Abdul-Khaliq H
Am Heart J; 2010 Dec; 160(6):1105-12. PubMed ID: 21146665
[TBL] [Abstract][Full Text] [Related]
10. Association between growth differentiation factor-15 and chronic heart failure in coronary atherosclerosis patients.
Zhu ZD; Sun T
Genet Mol Res; 2015 Mar; 14(1):2225-33. PubMed ID: 25867369
[TBL] [Abstract][Full Text] [Related]
11. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
[TBL] [Abstract][Full Text] [Related]
12. Incremental prognostic power of novel biomarkers (growth-differentiation factor-15, high-sensitivity C-reactive protein, galectin-3, and high-sensitivity troponin-T) in patients with advanced chronic heart failure.
Lok DJ; Klip IT; Lok SI; Bruggink-André de la Porte PW; Badings E; van Wijngaarden J; Voors AA; de Boer RA; van Veldhuisen DJ; van der Meer P
Am J Cardiol; 2013 Sep; 112(6):831-7. PubMed ID: 23820571
[TBL] [Abstract][Full Text] [Related]
13. Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension.
Nickel N; Kempf T; Tapken H; Tongers J; Laenger F; Lehmann U; Golpon H; Olsson K; Wilkins MR; Gibbs JS; Hoeper MM; Wollert KC
Am J Respir Crit Care Med; 2008 Sep; 178(5):534-41. PubMed ID: 18565955
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial.
Wallentin L; Lindholm D; Siegbahn A; Wernroth L; Becker RC; Cannon CP; Cornel JH; Himmelmann A; Giannitsis E; Harrington RA; Held C; Husted S; Katus HA; Mahaffey KW; Steg PG; Storey RF; James SK;
Circulation; 2014 Jan; 129(3):293-303. PubMed ID: 24170388
[TBL] [Abstract][Full Text] [Related]
15. Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction.
Izumiya Y; Hanatani S; Kimura Y; Takashio S; Yamamoto E; Kusaka H; Tokitsu T; Rokutanda T; Araki S; Tsujita K; Tanaka T; Yamamuro M; Kojima S; Tayama S; Kaikita K; Hokimoto S; Ogawa H
Can J Cardiol; 2014 Mar; 30(3):338-44. PubMed ID: 24484911
[TBL] [Abstract][Full Text] [Related]
16. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication.
Diller GP; Dimopoulos K; Okonko D; Li W; Babu-Narayan SV; Broberg CS; Johansson B; Bouzas B; Mullen MJ; Poole-Wilson PA; Francis DP; Gatzoulis MA
Circulation; 2005 Aug; 112(6):828-35. PubMed ID: 16061735
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of growth differentiation factor-15 and β2-microglobulin in children with congenital heart disease combined with chronic heart failure and its relationship with cardiac function.
Zhou XJ; Zhang X; Zhang J; Zhou L; Zhou TT; Zhang JW
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8096-8103. PubMed ID: 32767337
[TBL] [Abstract][Full Text] [Related]
18. Growth differentiation factor 15 as a useful biomarker of heart failure in young patients with unrepaired congenital heart disease of left to right shunt.
Kagiyama Y; Yatsuga S; Kinoshita M; Koteda Y; Kishimoto S; Koga Y; Suda K
J Cardiol; 2020 Jun; 75(6):697-701. PubMed ID: 31883956
[TBL] [Abstract][Full Text] [Related]
19. Growth differentiation factor-15 as candidate predictor for mortality in adults with pulmonary hypertension.
Geenen LW; Baggen VJM; Kauling RM; Koudstaal T; Boomars KA; Boersma E; Roos-Hesselink JW; van den Bosch AE
Heart; 2020 Mar; 106(6):467-473. PubMed ID: 31492701
[TBL] [Abstract][Full Text] [Related]
20. Growth differentiation factor 15: an additional diagnostic tool for the risk stratification of developing heart failure in patients with operated congenital heart defects?
Norozi K; Buchhorn R; Yasin A; Geyer S; Binder L; Seabrook JA; Wessel A
Am Heart J; 2011 Jul; 162(1):131-5. PubMed ID: 21742099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
